Table 2. Systemic and topical OVA sensitization results in inflammation, disturbs epidermal barrier homeostasis, and induces PPARδ target gene expression in skin.
Fold change | |||
Gene name | Symbol | OVA i.p. | OVA i.p.+e.c. |
Immune response | |||
Keratin 17 | Krt17 | 1.6±0.2* | 1.7±0.2** |
Th1-type | |||
Interleukin 12A | Il12a | 1639±719 | 2613±740* |
Interferon γ | Ifng | 11.1±5.4 | 22.1±2.8** |
Th2-type | |||
Interleukin 4 | Il4 | 11.7±4.5 | 92.7±30.9** # |
Interleukin 10 | Il10 | 12.4±5.5 | 32.7±13.1* |
Chemokine (CC motif) ligand 11/eotaxin 1 | Ccl11 | 0.2±0.2 | 13.8±5.1* # |
Chemokine (CC motif) receptor 3 | Ccr3 | 63.7±34.4 | 1763±534*** ## |
Epidermal barrier homeostasis | |||
ATP-binding cassette A121 | Abca12 | 0.3±0*** | 0.6±0.1*** ## |
Involucrin | Ivl | 0.6±0.1* | 0.4±0*** |
Loricrin | Lor | 0.5±0* | 0.8±0.1# |
Serine peptidase inhibitor, Kazal-type 5 | Spink5 | 0.2±0*** | 0.4±0*** |
Matrix metalloproteinase 9 | Mmp9 | 0.1±0*** | 0.6±0.1## |
S100 calcium binding protein A7A/psoriasin | S100a7a | 2.6±0.3** | 2.1±0.3* |
3-Hydroxy-3-methylglutaryl-CoA synthase 21 | Hmgcs2 | 0.4±0.1 | 4.4±1.1** ## |
Serine palmitoyltransferase long chain base subunit 2 | Sptlc2 | 1.2±0.3 | 33.8±10.6** ## |
UDP-glucose ceramide glucosyltransferase | Ugcg | 196±16.9*** | 161±14.4*** |
Alkaline ceramidase 1 | Acer1 | 2.2±0.6 | 3.9±0.3*** # |
PPARδ signaling | |||
Peroxisome proliferator-activated receptor δ | Ppard | 0.4±0** | 0.6±0* |
Fatty acid-binding protein 5 | Fabp5 | 1.7±0.3 | 2.2±0.2** |
ATP-binding cassette A121 | Abca12 | 0.3±0*** | 0.6±0.1*** ## |
Keratin 6B | Krt6b | 5.8±0.6 | 632±177** ## |
Keratin 16 | Krt16 | 0.5±0 | 5.7±1.2*** ### |
Heparin-binding EGF-like growth factor | Hbegf | 1.1±0.1 | 2.1±0.3* # |
3-Hydroxy-3-methylglutaryl-CoA synthase 21 | Hmgcs2 | 0.4±0.1 | 4.4±1.1** ## |
e.c., epicutaneous; i.p., intraperitoneal; OVA, ovalbumin; Th, T-helper cell.
Enumerated twice because the gene is relevant for two pathways.
Fold change data are expressed as mean ± SEM (n = 6) and were determined in skin specimen of sensitized mice by TLDA or qRT-PCR. Statistical significance (p) was tested using one-way ANOVA followed by Tukey’s multiple comparison test.
p<0.05,
p<0.01,
p<0.001, versus control (PBS i.p.);
p<0.05,
p<0.01, and ### p<0.001, versus OVA i.p.